Skip to content
Companies

Delphinus Medical Technologies

3D ultrasound breast imaging without compression

Raised to date

$27.6M

of $27.6M offered across 1 Form D filing

Investors
8
Last filed
Apr 3, 2025

About

Delphinus Medical Technologies, Inc. is a pioneering medical imaging firm based in Novi, Michigan, dedicated to transforming breast cancer screening, especially for women with dense breast tissue. The company is renowned for developing the SoftVue™ system, which utilizes advanced ultrasound technology to improve cancer detection and streamline the screening process.

Delphinus stands out due to its innovative SoftVue™ system, which provides a radiation-free and non-compressive breast cancer screening option that significantly enhances detection rates in women with dense breast tissue.

Funding

  • Security to be acquiredFiled Apr 3, 2025Form D/A
    $27.6M/ $27.6M

Product

SoftVue™ 3D Whole Breast Ultrasound Tomography System

Breast Cancer Screening

The SoftVue™ system is an FDA-approved medical device that utilizes revolutionary circular array transducer technology to produce three-dimensional whole breast ultrasound images. The device uniquely employs sound and water for imaging, avoiding the discomfort associated with compression and the risks related to radiation exposure found in traditional mammography.

  • Non-invasive and comfortable – no compression or radiation
  • Quick scanning – complete breast scans in just 2-3 minutes
  • Enhanced cancer detection – identifies up to 20-25% more cancers when used with mammography

Built for

Healthcare providers and imaging centers

People on file